SPYA:XETRA:XETRA-SSgA SPDR ETFs Europe I Public Limited Company - SPDR MSCI EM Asia UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 77.28

Change

+1.85 (+2.45)%

Market Cap

USD 0.86B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.23 (-0.43%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.36%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.18 (-0.64%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.37%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.01 (-0.02%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.88 (+0.62%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.21 (-0.45%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.13 (-0.26%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.32 (+0.33%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.04 (+0.37%)

USD 80.38B

ETFs Containing SPYA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.18% 91% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.18% 91% A- 88% B+
Trailing 12 Months  
Capital Gain 27.46% 77% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.46% 76% C+ 75% C
Trailing 5 Years  
Capital Gain 39.92% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.92% 55% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 3.97% N/A N/A 47% F
Dividend Return 3.97% N/A N/A 45% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.51% N/A N/A 41% F
Risk Adjusted Return 24.05% N/A N/A 38% F
Market Capitalization 0.86B 75% C 66% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike